Home » Biogen » Morgan Stanley raises Biogen (NASDAQ:BIIB) price target from $363 to $381 Morgan Stanley raises Biogen (NASDAQ:BIIB) price target from $363 to $381 Posted on September 5, 2023 By legume No Comments on Morgan Stanley raises Biogen (NASDAQ:BIIB) price target from $363 to $381 Morgan Stanley analyst Matthew Harrison maintains Biogen (NASDAQ:BIIB) with a Overweight and raises the price target from $363 to $381. Health Care Tags:Biogen, Morgan Stanley